The H2med project, designed to be Europe’s first major hydrogen transportation corridor, has confirmed the technical feasibility of its centerpiece, the BarMar hydrogen pipeline, which will connect Barcelona and Marseille.

Following extensive geophysical prospecting campaigns in 2024 and summer 2025, and subsequent in-depth engineering analyses, project partners announced that the proposed BarMar route presents no major physical constraints. 

The comprehensive studies found that seabed conditions and terrain do not pose critical challenges, and all identified infrastructure crossings, including pipelines, are considered manageable using established engineering practices.

This successful technical assessment allows the H2med partners to accelerate the project schedule, with the Commercial Operation Date (COD) for both the BarMar pipeline and the associated CelZa project now specified for 2032. 

This updated timeline accounts for the complex technical requirements and the need for synchronized permitting and authorization processes as participating nations develop their own national hydrogen networks. 

The H2med corridor is intended to be the backbone connecting these networks, making precise synchronization essential.

Political support for the corridor was recently reaffirmed during a joint Council of Ministers meeting on August 29, 2025, when France and Germany reiterated their commitment to its timely implementation.

The H2med project has been gaining significant momentum since securing Project of Common Interest (PCI) status from the European Commission in 2024. 

Key developments in 2025 have included the signing of Grant Agreements with the European Climate, Infrastructure and Environment Executive Agency (CINEA) for the BarMar and CelZa projects, and the establishment of the BarMar company in July to specifically develop the interconnection.

Furthermore, the project’s success in pioneering cross-border governance and regulatory harmonization is expected to serve as a blueprint for future transnational energy initiatives. Market support is also growing, with the H2med Alliance expanding to 49 members across the entire hydrogen value chain.